Related Experiment Video
Updated: Jul 7, 2025

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Racial, Ethnic, and Geographic Disparities in Immunization Rates Among Patients With Inflammatory Bowel Disease
Poonam Beniwal-Patel1, Gabrielle Waclawik2, Keely Browning1
1Medical College of Wisconsin, Division of Gastroenterology and Hepatology, Milwaukee, WI, USA.
Racial and ethnic disparities in influenza vaccine uptake are evident among patients with inflammatory bowel disease (IBD). Black patients and those in underserved areas showed lower immunization rates, highlighting a need for targeted interventions.
Area of Science:
- Gastroenterology and Hepatology
- Immunology
- Public Health
Background:
- Racial and ethnic disparities in healthcare are well-documented.
- These disparities may extend to vaccine uptake in patients with inflammatory bowel disease (IBD).
- Influenza vaccine uptake in IBD patients requires investigation for potential inequities.
Purpose of the Study:
- To determine if racial, ethnic, or geographic disparities exist in influenza vaccine uptake among patients with IBD.
- To assess disparities in pneumococcal, zoster, and hepatitis B vaccine uptake in this population.
Main Methods:
- Multicenter, retrospective cohort study.
- Inclusion of adult patients with IBD from two tertiary referral centers (September 2019 - February 2020).
- Analysis of influenza, pneumococcal, zoster, and hepatitis B vaccine uptake based on race, ethnicity, and geographic location.
Main Results:
- Non-Hispanic White patients and older individuals were more likely to receive the influenza vaccine.
- Black patients and those residing in underserved geographic areas demonstrated lower influenza vaccine uptake.
- Similar racial/ethnic and geographic disparities were observed for pneumococcal, zoster, and hepatitis B vaccines.
Conclusions:
- Significant racial, ethnic, and geographic disparities in vaccine uptake exist among IBD patients.
- Patients from medically underserved areas are particularly vulnerable to these inequities.
- Further research is needed to identify patient, provider, and system-level strategies to address these disparities.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

